Complete percutaneous angio-guided approach using preclosing for venoarterial extracorporeal membrane oxygenation implantation and explantation in patients with refractory cardiogenic shock or cardiac arrest.
Cardiac arrest
Cardiogenic shock
Closure device
ECMO
Percutaneous cannulation
Journal
Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902
Informations de publication
Date de publication:
07 03 2021
07 03 2021
Historique:
received:
10
12
2020
accepted:
01
03
2021
entrez:
8
3
2021
pubmed:
9
3
2021
medline:
7
9
2021
Statut:
epublish
Résumé
The approach for veno-arterial extracorporeal membrane oxygenation implantation (VA-ECMO) in patients with cardiogenic shock can be either surgical or percutaneous. Complete angio-guided percutaneous implantation and explantation could decrease vascular complications. We sought to describe the initial results of complete percutaneous angio-guided ECMO implantation and explantation using preclosing. All consecutive patients who underwent peripheral femoro-femoral VA-ECMO percutaneous implantation for refractory cardiogenic shock or cardiac arrest were enrolled in a prospective registry (03/2018-12/2020). Percutaneous preclosing using two closing devices (Perclose ProGlide, Abbott) inserted before cannulation was used in both femoral artery and vein. Explantation was performed using a crossover technique under angiographic guidance. The occurrence of vascular complication was recorded. Among the 56 patients who underwent percutaneous VA-ECMO implantation for cardiogenic shock or refractory cardiac arrest, 41 underwent preclosing. Femoral vessel cannulation was successful in all patients and total cannulation time was 20 (10-40) min. Weaning from ECMO was possible in 22/41 patients (54%) and 12 (29%) patients were alive at day 30. Significant vascular complications occurred in 2/41 patients. Percutaneous decannulation was performed in 20 patients with 19/20 technical success rate. All femoral arteries and veins were properly closed using the pre-closing devices without bleeding on the angiographic control except for one patient in whom surgical closure of the artery was required. No patient required transfusion for access related significant bleeding and no other vascular complication occurred. Furthermore, no groin infection was observed after full percutaneous implantation and removal of ECMO. Emergent complete percutaneous angio-guided VA-ECMO implantation and explantation using pre-closing technique can be an attractive strategy in patients referred for refractory cardiogenic shock.
Sections du résumé
BACKGROUND
The approach for veno-arterial extracorporeal membrane oxygenation implantation (VA-ECMO) in patients with cardiogenic shock can be either surgical or percutaneous. Complete angio-guided percutaneous implantation and explantation could decrease vascular complications. We sought to describe the initial results of complete percutaneous angio-guided ECMO implantation and explantation using preclosing.
METHODS
All consecutive patients who underwent peripheral femoro-femoral VA-ECMO percutaneous implantation for refractory cardiogenic shock or cardiac arrest were enrolled in a prospective registry (03/2018-12/2020). Percutaneous preclosing using two closing devices (Perclose ProGlide, Abbott) inserted before cannulation was used in both femoral artery and vein. Explantation was performed using a crossover technique under angiographic guidance. The occurrence of vascular complication was recorded.
RESULTS
Among the 56 patients who underwent percutaneous VA-ECMO implantation for cardiogenic shock or refractory cardiac arrest, 41 underwent preclosing. Femoral vessel cannulation was successful in all patients and total cannulation time was 20 (10-40) min. Weaning from ECMO was possible in 22/41 patients (54%) and 12 (29%) patients were alive at day 30. Significant vascular complications occurred in 2/41 patients. Percutaneous decannulation was performed in 20 patients with 19/20 technical success rate. All femoral arteries and veins were properly closed using the pre-closing devices without bleeding on the angiographic control except for one patient in whom surgical closure of the artery was required. No patient required transfusion for access related significant bleeding and no other vascular complication occurred. Furthermore, no groin infection was observed after full percutaneous implantation and removal of ECMO.
CONCLUSION
Emergent complete percutaneous angio-guided VA-ECMO implantation and explantation using pre-closing technique can be an attractive strategy in patients referred for refractory cardiogenic shock.
Identifiants
pubmed: 33678169
doi: 10.1186/s13054-021-03522-8
pii: 10.1186/s13054-021-03522-8
pmc: PMC7938494
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
93Références
J Vasc Surg. 2017 Apr;65(4):1074-1079
pubmed: 28342510
Intensive Care Med. 2018 Jun;44(6):760-773
pubmed: 29767322
Crit Care Med. 2010 Sep;38(9):1810-7
pubmed: 20543669
Circulation. 2008 Feb 5;117(5):686-97
pubmed: 18250279
Crit Care Med. 2020 Dec;48(12):e1269-e1277
pubmed: 33105148
J Thorac Cardiovasc Surg. 2013 Jan;145(1):6-23
pubmed: 23084102
J Cardiovasc Surg (Torino). 1996 Dec;37(6):557-9
pubmed: 9016966
J Am Coll Cardiol. 2018 Jul 10;72(2):173-182
pubmed: 29976291
Cardiovasc Intervent Radiol. 2020 Jul;43(7):1084-1090
pubmed: 32419078
J Vasc Surg. 2016 Apr;63(4):998-1003.e1
pubmed: 26826058
Crit Care Explor. 2019 Jun 26;1(6):e0018
pubmed: 32166262
Catheter Cardiovasc Interv. 2013 Nov 1;82(5):E734-41
pubmed: 23765732
Crit Care Med. 2008 Jan;36(1 Suppl):S66-74
pubmed: 18158480
J Vasc Surg. 2003 Jul;38(1):78-82
pubmed: 12844093
Ann Thorac Surg. 2019 Mar;107(3):809-816
pubmed: 30365965
J Invasive Cardiol. 2020 Feb;32(2):64-69
pubmed: 31841997
Eur Heart J Acute Cardiovasc Care. 2020 Jun;9(4):342-347
pubmed: 32363881
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
Clin Cardiol. 2019 Apr;42(4):459-466
pubmed: 30820972
JACC Cardiovasc Interv. 2011 Aug;4(8):861-7
pubmed: 21851899
Int J Cardiol. 2018 Oct 15;269:45-50
pubmed: 30077527
Crit Care Med. 2008 May;36(5):1404-11
pubmed: 18434909
Arch Cardiovasc Dis. 2012 Jan;105(1):5-12
pubmed: 22369912
Intensive Care Med. 2018 Dec;44(12):2153-2161
pubmed: 30430207
Thorac Cardiovasc Surg. 2011 Mar;59(2):103-7
pubmed: 21384306
Eur J Cardiothorac Surg. 2020 Aug 1;58(2):371-378
pubmed: 32083665